Table 3.
Method | Setting / scenariob | 5-year Relative Survival (RS) | Loss in life expectancy (LLE)a,f | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PE | SE | LCI | UCI | RPc | PE | SE | LCI | UCI | RP | ||
men, 55 years at diagnosis | |||||||||||
Conventionald | 2 | 0.639 | 0.026 | 0.585 | 0.687 | 0.00 | 12.74 | 0.87 | 11.03 | 14.44 | 0.00 |
Bootstrape | F | 0.639 | 0.026 | 0.585 | 0.687 | 0.00 | 12.74 | 0.87 | 11.03 | 14.44 | 0.10 |
-based | G | 0.639 | 0.026 | 0.585 | 0.687 | 0.01 | 12.74 | 0.87 | 11.02 | 14.45 | 0.86 |
H | 0.639 | 0.026 | 0.585 | 0.687 | 0.23 | 12.72 | 0.94 | 10.87 | 14.57 | 17.68 | |
I | 0.640 | 0.026 | 0.586 | 0.689 | 2.32 | 12.73 | 1.47 | 9.84 | 15.62 | 186.49 | |
men, 65 years at diagnosis | |||||||||||
Conventional | 2 | 0.636 | 0.021 | 0.593 | 0.675 | 0.00 | 7.83 | 0.45 | 6.95 | 8.70 | 0.00 |
Bootstrap | F | 0.636 | 0.021 | 0.593 | 0.675 | 0.00 | 7.83 | 0.45 | 6.95 | 8.70 | 0.20 |
-based | G | 0.636 | 0.021 | 0.593 | 0.675 | 0.03 | 7.83 | 0.45 | 6.95 | 8.71 | 1.81 |
H | 0.636 | 0.021 | 0.593 | 0.676 | 0.55 | 7.82 | 0.52 | 6.80 | 8.85 | 37.16 | |
I | 0.638 | 0.022 | 0.594 | 0.679 | 5.58 | 7.89 | 1.00 | 5.92 | 9.85 | 403.74 | |
men, 75 years at diagnosis | |||||||||||
Conventional | 2 | 0.629 | 0.021 | 0.586 | 0.669 | 0.00 | 4.34 | 0.24 | 3.86 | 4.81 | 0.00 |
Bootstrap | F | 0.629 | 0.021 | 0.586 | 0.669 | 0.01 | 4.34 | 0.24 | 3.86 | 4.81 | 0.37 |
-based | G | 0.629 | 0.021 | 0.586 | 0.669 | 0.07 | 4.34 | 0.25 | 3.86 | 4.82 | 3.21 |
H | 0.629 | 0.021 | 0.586 | 0.670 | 1.43 | 4.34 | 0.31 | 3.73 | 4.95 | 65.54 | |
I | 0.630 | 0.023 | 0.584 | 0.673 | 13.86 | 4.45 | 0.73 | 3.02 | 5.88 | 810.92 | |
men, 85 years at diagnosis | |||||||||||
Conventional | 2 | 0.581 | 0.030 | 0.520 | 0.638 | 0.00 | 2.03 | 0.14 | 1.75 | 2.30 | 0.00 |
Bootstrap | F | 0.581 | 0.030 | 0.520 | 0.638 | 0.03 | 2.03 | 0.14 | 1.75 | 2.30 | 0.46 |
-based | G | 0.581 | 0.030 | 0.519 | 0.638 | 0.20 | 2.03 | 0.14 | 1.74 | 2.31 | 3.96 |
H | 0.580 | 0.031 | 0.517 | 0.638 | 3.95 | 2.04 | 0.19 | 1.66 | 2.41 | 84.42 | |
I | 0.575 | 0.036 | 0.502 | 0.642 | 41.27 | 2.16 | 0.53 | 1.13 | 3.19 | 1286.02 | |
women, 55 years at diagnosis | |||||||||||
Conventional | 2 | 0.662 | 0.025 | 0.611 | 0.709 | 0.00 | 12.26 | 0.92 | 10.46 | 14.06 | 0.00 |
Bootstrap | F | 0.662 | 0.025 | 0.611 | 0.709 | 0.00 | 12.26 | 0.92 | 10.46 | 14.06 | 0.05 |
-based | G | 0.662 | 0.025 | 0.611 | 0.709 | 0.01 | 12.26 | 0.92 | 10.45 | 14.06 | 0.48 |
H | 0.663 | 0.025 | 0.611 | 0.709 | 0.36 | 12.25 | 0.96 | 10.36 | 14.14 | 10.37 | |
I | 0.665 | 0.025 | 0.612 | 0.711 | 4.08 | 12.18 | 1.30 | 9.64 | 14.72 | 99.20 | |
women, 65 years at diagnosis | |||||||||||
Conventional | 2 | 0.660 | 0.020 | 0.619 | 0.697 | 0.00 | 7.93 | 0.48 | 6.99 | 8.88 | 0.00 |
Bootstrap | F | 0.660 | 0.020 | 0.619 | 0.697 | 0.01 | 7.93 | 0.48 | 6.99 | 8.88 | 0.10 |
-based | G | 0.660 | 0.020 | 0.619 | 0.697 | 0.02 | 7.93 | 0.48 | 6.98 | 8.88 | 1.04 |
H | 0.660 | 0.020 | 0.619 | 0.697 | 0.48 | 7.93 | 0.53 | 6.88 | 8.97 | 21.90 | |
I | 0.662 | 0.020 | 0.621 | 0.701 | 5.50 | 7.93 | 0.85 | 6.26 | 9.61 | 214.02 | |
women, 75 years at diagnosis | |||||||||||
Conventional | 2 | 0.653 | 0.020 | 0.612 | 0.692 | 0.00 | 4.73 | 0.28 | 4.18 | 5.29 | 0.00 |
Bootstrap | F | 0.653 | 0.020 | 0.612 | 0.692 | 0.01 | 4.73 | 0.28 | 4.18 | 5.29 | 0.18 |
-based | G | 0.653 | 0.020 | 0.612 | 0.692 | 0.03 | 4.73 | 0.29 | 4.17 | 5.29 | 1.71 |
H | 0.654 | 0.020 | 0.612 | 0.692 | 0.66 | 4.73 | 0.33 | 4.09 | 5.38 | 36.30 | |
I | 0.655 | 0.021 | 0.612 | 0.695 | 6.68 | 4.80 | 0.64 | 3.55 | 6.05 | 406.77 | |
women, 85 years at diagnosis | |||||||||||
Conventional | 2 | 0.607 | 0.027 | 0.553 | 0.658 | 0.00 | 2.35 | 0.16 | 2.04 | 2.67 | 0.00 |
Bootstrap | F | 0.608 | 0.027 | 0.553 | 0.658 | 0.03 | 2.35 | 0.16 | 2.03 | 2.67 | 0.25 |
-based | G | 0.607 | 0.027 | 0.552 | 0.658 | 0.15 | 2.36 | 0.16 | 2.03 | 2.68 | 2.28 |
H | 0.607 | 0.027 | 0.551 | 0.658 | 3.13 | 2.37 | 0.20 | 1.98 | 2.75 | 48.53 | |
I | 0.602 | 0.031 | 0.539 | 0.660 | 32.32 | 2.48 | 0.47 | 1.56 | 3.39 | 718.93 |
aLLE is presented in years
bSee Table 1 for information on the different settings and scenarios
cRP is presented in %
dConventional refers to the standard method for estimating SEs, where the general population mortality is assumed to be measured without uncertainty
eBootstrap-used refers to the parametric bootstrap approach used for including uncertainty in population mortality rates in the estimation of SEs
fLLE estimates are presented for the Stockholm region